Literature DB >> 8627051

High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis.

S Mahanty1, S N Mollis, M Ravichandran, J S Abrams, V Kumaraswami, K Jayaraman, E A Ottesen, T B Nutman.   

Abstract

To determine whether counterregulation by interleukin (IL)-10 plays a role in the generation or maintenance of the antigen-specific hyporesponsiveness seen in asymptomatic microfilaremic (MF) patients, parasite antigen (PAg)- and nonparasite antigen (NPAg)-driven IL-10 production by peripheral blood mononuclear cells (PBMC) was studied in 10 MF patients and in ll patients with chronic lymphatic pathology (CP). PBMC from MF patients spontaneously secreted 10-fold more IL-10 than did PBMC from patients with CP. PAg also induced significantly more IL-10 production by PBMC from CP patients. There was a negative correlation between PAg driven IL-10 production by PBMC and PAg-specific T cell proliferation in the MF group. IL-10 secretion by plastic adherent cells from MF persons was higher in response to PAg than NPAg, whereas IL-6 and tumor necrosis factor-alpha secretion were equivalent for PAg and NPAg, suggesting that PAg preferentially induces IL-10 secretion in these cells. Thus, PAg-induced IL-10 likely plays an important role in down-regulating antigen-specific proliferative responses in MF patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627051     DOI: 10.1093/infdis/173.3.769

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  53 in total

Review 1.  Immunology of parasitic helminth infections.

Authors:  Andrew S MacDonald; Maria Ilma Araujo; Edward J Pearce
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  Filarial antigens impair the function of human dendritic cells during differentiation.

Authors:  R T Semnani; H Sabzevari; R Iyer; T B Nutman
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

3.  Immune responses to recombinant Brugia malayi pepsin inhibitor homolog (Bm-33) in patients with human lymphatic filariaisis.

Authors:  N S A Krushna; C Shiny; G Manokaran; S Elango; S Babu; R B Narayanan
Journal:  Parasitol Res       Date:  2010-10-07       Impact factor: 2.289

4.  Human bancroftian filariasis - a role for antibodies to parasite carbohydrates.

Authors:  M C Mohanty; A K Satapathy; P K Sahoo; B Ravindran
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

Review 5.  CD4+ regulatory cells as a potential immunotherapy.

Authors:  Zoltán Fehérvari; Shimon Sakaguchi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

Review 6.  Signalling mechanisms underlying subversion of the immune response by the filarial nematode secreted product ES-62.

Authors:  Helen S Goodridge; Gillian Stepek; William Harnett; Margaret M Harnett
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

7.  At homeostasis filarial infections have expanded adaptive T regulatory but not classical Th2 cells.

Authors:  Simon Metenou; Benoit Dembele; Siaka Konate; Housseini Dolo; Siaka Y Coulibaly; Yaya I Coulibaly; Abdallah A Diallo; Lamine Soumaoro; Michel E Coulibaly; Dramane Sanogo; Salif S Doumbia; Sekou F Traoré; Siddhartha Mahanty; Amy Klion; Thomas B Nutman
Journal:  J Immunol       Date:  2010-03-31       Impact factor: 5.422

Review 8.  Helminth infections and host immune regulation.

Authors:  Henry J McSorley; Rick M Maizels
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 9.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory factor.

Authors:  D V Pastrana; N Raghavan; P FitzGerald; S W Eisinger; C Metz; R Bucala; R P Schleimer; C Bickel; A L Scott
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.